{"id":355345,"date":"2025-08-28T18:22:14","date_gmt":"2025-08-28T18:22:14","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-avantor\/"},"modified":"2025-08-28T18:22:14","modified_gmt":"2025-08-28T18:22:14","slug":"how-to-buy-avantor","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-avantor\/","title":{"rendered":"How to buy Avantor, Inc. (AVTR) shares – Investment in Avantor, Inc. (AVTR) stock"},"content":{"rendered":"
text<\/div><\/div>","protected":false},"excerpt":{"rendered":"

text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-355345","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Avantor, Inc. (AVTR) Shares - Investment in Avantor, Inc. (AVTR) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Avantor, Inc. (AVTR) Shares - Investment in Avantor, Inc. (AVTR) Stock"},"description":"Learn how to buy Avantor, Inc. (AVTR) shares and make smart investment decisions. Discover current stock performance, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Avantor, Inc. (AVTR) shares and make smart investment decisions. Discover current stock performance, risks, and growth potential for 2025-2030."},"intro":"Thinking about investing in a company that powers scientific breakthroughs worldwide? Avantor, Inc. (AVTR) supplies mission-critical products to life sciences and technology industries \u2013 from cancer research labs to semiconductor manufacturing. This isn't just another stock; it's a piece of the infrastructure behind modern medicine and innovation. Let's explore why AVTR deserves your attention and how you can become a shareholder.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a company that powers scientific breakthroughs worldwide? Avantor, Inc. (AVTR) supplies mission-critical products to life sciences and technology industries \u2013 from cancer research labs to semiconductor manufacturing. This isn't just another stock; it's a piece of the infrastructure behind modern medicine and innovation. Let's explore why AVTR deserves your attention and how you can become a shareholder."},"body_html":"

\ud83d\udcc8 Avantor Stock Analysis: Current Price and Critical Dates<\/h2>

As of August 28, 2025, Avantor, Inc. (AVTR) trades at $13.30<\/strong> on the NYSE. Mark your calendar: October 24, 2025<\/strong> is absolutely critical \u2013 that's when Avantor releases its Q3 earnings report. Historically, these quarterly announcements have moved the stock dramatically.<\/p>

How Earnings Reports Impact AVTR Stock<\/h3>

Looking at recent history, the pattern is clear. On August 1, 2025, when Avantor reported Q2 results, the stock plunged 14.77%<\/strong> in a single day (Nasdaq<\/a>). The company reported mixed results: revenue of $1.68 billion (beating estimates by $8.8 million) but EPS of $0.24 missing by just $0.01 (Zacks<\/a>).<\/p>

The market reaction was brutal but predictable. Here's how AVTR typically behaves around earnings:<\/p>
Date<\/th>Event<\/th>Price Change<\/th>Duration<\/th><\/tr> <\/thead>
Aug 1, 2025<\/td>Q2 Earnings<\/td>-14.77%<\/td>1 day<\/td><\/tr>
May 2, 2025<\/td>Q1 Earnings<\/td>-8.2%<\/td>3 days<\/td><\/tr>
Feb 6, 2025<\/td>Q4 2024<\/td>+3.1%<\/td>Beat estimates<\/td><\/tr>
Nov 7, 2024<\/td>Q3 2024<\/td>-5.8%<\/td>Margin pressure<\/td><\/tr>
Aug 8, 2024<\/td>Q2 2024<\/td>+2.3%<\/td>Solid growth<\/td><\/tr> <\/tbody> <\/table>

Trend Insight<\/strong>: Avantor shares are extremely sensitive to earnings surprises. Even small misses trigger significant sell-offs, while beats provide modest gains. This creates opportunities for patient investors who can stomach short-term volatility.<\/p> [cta_green text=\"Start trading\"]

\ud83d\udd04 6-Month Price Journey: Rollercoaster Ride<\/h2>

Avantor shares have experienced a turbulent six months, declining approximately 38-42% year-to-date<\/strong> (StockInvest<\/a>). Here's the monthly breakdown:<\/p>

February 2025<\/strong>: Around $21.50 - Post-Q4 earnings optimism March 2025<\/strong>: Dropped to $18.20 - Market concerns about lab spending April 2025<\/strong>: Further decline to $16.80 - Education sector headwinds May 2025<\/strong>: $15.40 after Q1 earnings miss June 2025<\/strong>: Stabilized near $14.80 - Cost cutting announcements July 2025<\/strong>: $13.90 - Continued pressure from policy changes August 2025<\/strong>: $13.30 - Post-Q2 earnings collapse<\/p>

The primary drivers of this decline include reduced government and education funding for laboratory equipment, competitive pressures in the biochemical supply chain, and overall economic uncertainty affecting research budgets.<\/p>

Despite the challenging environment, Avantor maintained a robust EBIT margin of 15.8%<\/strong> and gross margin of 33.6%<\/strong> (PR Newswire<\/a>), demonstrating underlying operational strength.<\/p>

\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>

Based on current analyst projections and company fundamentals, here's what to expect:<\/p>

2025 (Year-End)<\/strong>: $14-16 range \u2192 HOLD<\/strong> Analysts are mixed but cautious. Some project $14.58 (CoinCodex<\/a>) while others see potential for $28+ in optimistic scenarios. The reality likely lies somewhere in between.<\/p>

2026<\/strong>: $15-18 \u2192 ACCUMULATE<\/strong> Cost savings from the $400 million transformation program should start showing results. If management executes well, margins could expand significantly.<\/p>

2028<\/strong>: $20-25 \u2192 BUY<\/strong> By 2028, the bioprocessing business should be driving substantial growth. Market conditions in life sciences research expected to improve.<\/p>

2030<\/strong>: $25-35+ \u2192 STRONG BUY<\/strong> Long-term demographic trends (aging population, increased healthcare spending) and technological advancement should benefit Avantor significantly.<\/p>

Verdict<\/strong>: Current price offers attractive entry for long-term investors willing to wait 2-3 years for the turnaround story to play out.<\/p>

\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>

Risks to Consider<\/strong>: - High volatility<\/strong>: Daily swings of 5-6% are common - Regulatory changes<\/strong>: Government funding cuts hurt education sales - Competition<\/strong>: Intense pressure in laboratory supplies market - Economic sensitivity<\/strong>: Research budgets get cut during recessions - Execution risk<\/strong>: $400M cost cutting program must deliver<\/p>

Green Lights for 2025-2026<\/strong>: - Major contract extensions<\/strong>: Secured several with leading pharma companies (Avantor IR<\/a>) - New leadership<\/strong>: Emmanuel Ligner appointed CEO in August - fresh perspective - Cost transformation<\/strong>: $400M program underway with $1.5B debt reduction already achieved - Industry trends<\/strong>: Life sciences growing long-term despite short-term headwinds - Undervalued<\/strong>: Trading at multi-year lows despite solid margins<\/p>

\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>
  1. Wait for earnings dip<\/strong>: October 24th will likely create buying opportunity if history repeats<\/li>
  2. Dollar-cost average<\/strong>: Invest fixed amounts monthly rather than trying to time bottom<\/li>
  3. Allocate wisely<\/strong>: No more than 5% of portfolio in high-volatility stocks like AVTR<\/li>
  4. Set stop-losses<\/strong>: Protect yourself from further downside below $12<\/li> <\/ol>

    Humorous take: \"Trading AVTR is like being in a relationship with a brilliant scientist \u2013 incredibly rewarding long-term but emotionally exhausting day-to-day. Bring patience and antacids.\"<\/p>

    \u2705 How to Buy Avantor, Inc. (AVTR) Shares - Step by Step<\/h2>
    Step<\/th>Action<\/th>Why It Matters<\/th><\/tr> <\/thead>
    1<\/td>Choose trading platform<\/td>Ensure it offers NYSE stocks and reasonable fees<\/td><\/tr>
    2<\/td>Open and fund account<\/td>Start with amount you're comfortable potentially losing<\/td><\/tr>
    3<\/td>Research current price<\/td>Check real-time quotes \u2013 AVTR trades during NYSE hours<\/td><\/tr>
    4<\/td>Place limit order<\/td>Set maximum price you'll pay (e.g., $13.50)<\/td><\/tr>
    5<\/td>Monitor position<\/td>Track earnings dates and industry news regularly<\/td><\/tr>
    6<\/td>Reinvest dividends<\/td>AVTR pays quarterly dividends \u2013 compound your returns<\/td><\/tr>
    7<\/td>Review quarterly<\/td>Assess management's progress on cost transformation<\/td><\/tr>
    8<\/td>Consider tax implications<\/td>Hold over 1 year for favorable long-term capital gains rates<\/td><\/tr> <\/tbody> <\/table>

    \ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>

    For those starting their investment journey, Pocket Option offers several advantages for buying Avantor shares:<\/p>